The event introduced the pharmaceutical giant’s new campus to guests within the real estate sector, and showcased the fully completed office building, and the partially completed lab building. MovePlan has been working with Sanofi for the past two years to deliver move and change management programs for the new headquarter campus. Located in Massachusetts’ latest development, Cambridge Crossing is a large-scale redevelopment project that is creating a new urban neighborhood and innovation hub at the intersection of Cambridge, Somerville and Boston in the US. It’s a high profile project and, when complete, will have over 4.5 million square feet of retail, residential and commercial space set in 43 acres.
MovePlan’s Senior Project Director, Kimberly Giles:“We are delighted to be Sanofi’s partner of choice on this large scale project. It was a complex project, marrying both move and change management for both head office employees and research and lab technicians. Overall, we transferred three locations into one, planning and supporting the move of approximately 1,500 head office staff into a new office building, and approximately 1,000 researchers into the lab. All had complex requirements, not least the transfer of thousands of live samples to the new site.”
The event provided guests from real estate and facility management roles with insight into the project behind the consolidation of Sanofi’s original Massachusetts sites into two newly developed buildings on one campus. Giles joined members of her team, who worked on the move and change management project, to conduct site tours and provide guests with insight into the strategic delivery of the project.
Kimberly Giles concluded: “It is very rewarding to see the project nearing completion, and the buildings come to life as employees settle into their new surroundings. We are honored to have had a chance to work on such a high profile project and one which we will be proud of for years to come.”
The project began at the end of 2020, and is due for final completion in early 2023.